Splenic Infarct Treatment & Management

  • Author: Manish Parikh, MD; Chief Editor: John Geibel, MD, DSc, MA   more...
 
Updated: Apr 4, 2012
 

Medical Therapy

Surgery is indicated only in the presence of complications. Otherwise, the infarcted spleen can be left in situ, and the patient is observed. Due to the rarity of this disorder and the largely anecdotal character of many reports, the roles of antibiotics and antiplatelet agents (for the treatment of thrombocytosis) have not been formally addressed. Similarly, no scientifically supported information exists regarding the possible increase in susceptibility to overwhelming postsplenectomy sepsis in these patients.

The principal mainstay of nonoperative therapy is analgesia with either narcotics or nonsteroidal anti-inflammatory agents and close follow-up. Many of the altitude-related episodes in patients with sickle cell disease can be safely treated with supportive care rather than with splenectomy.[11] Isolated splenic abscess can in certain circumstances be treated with percutaneous drainage alone, and splenectomy can be avoided. However, a patient with multiple splenic abscesses usually will require splenectomy.

Next

Surgical Therapy

  • For an infarcted spleen with any of the above-mentioned complications, splenectomy is required.
  • Because of the (albeit small) risk of fatal, overwhelming postsplenectomy sepsis, splenic preservation is preferable whenever possible.
  • In cases of torsion of a wandering spleen, splenopexy with splenic salvage is the procedure of choice in the well-perfused, noninfarcted spleen. Techniques include suturing the spleen to the surrounding structures, wrapping the organ in omentum or mesh prior to suture fixation, or placing it in a surgically created retroperitoneal pouch. This has been reported laparoscopically.[24]
  • Complications, such as bleeding or pseudocyst formation, also may be amenable to splenic salvage using techniques of partial splenectomy.
  • While a unilocular abscess can be managed successfully in select cases with percutaneous catheter drainage, some authors advocate splenectomy in all cases of splenic infarct and abscess, questioning the utility of preserving the residual, partially functioning spleen. This may be accomplished using traditional open techniques or with laparoscopic techniques.
  • Perisplenic inflammation and dense adhesions can make splenectomy difficult. Another choice is to perform preoperative splenic artery embolization; this purposely infarcts the remaining spleen and minimizes blood loss, which otherwise can be quite profuse in these difficult dissections. Intraoperative ligation of the splenic artery at the superior margin of the pancreas in the lesser sac is another alternative to minimize blood loss if the spleen is enlarged.
Previous
Next

Preoperative Details

  • The choice of preoperative antibiotics should be guided by the patient's clinical status and associated comorbidities. A first-generation cephalosporin usually is adequate.
  • Appropriate preoperative hydration is essential in anticipation of potential blood loss.
  • If splenectomy (rather than splenic preservation) is planned, the patient should receive the pneumococcal and Haemophilus influenza vaccine at least 2 weeks prior to the operation, if feasible.
  • Neoadjuvant chemotherapy in patients with hematologic malignancies (eg, chronic myeloid leukemia) can reduce spleen size and potentially increase the safety of the procedure.
  • Preoperative sequential compression devices and subcutaneous heparin can be used for deep venous thrombosis (DVT) prophylaxis.
Previous
Next

Intraoperative Details

  • The approach (eg, laparoscopy, midline laparotomy, or left subcostal incision) is determined by the underlying pathology/clinical scenario, as well as by the surgeon's preference. The presence of splenic infarct (or abscess) is not per se a contraindication for laparoscopy. Generally, the laparoscopic approach is contraindicated in emergent situations, such as hemorrhagic shock and spontaneous rupture. The surgeon's experience determines the point at which the enlarged spleen is too large to remove laparoscopically.
  • For the laparoscopic approach, patient position is key to the success of this operation. Choices include the "hanging spleen" technique, in which the patient is in the lateral decubitus position (as described for laparoscopic adrenalectomy). Another option is the "leaning spleen" technique, in which the patient is at a 45 º tilt. Both methods require a beanbag or jelly roll positioning pad. Once pneumoperitoneum is established, the splenocolic ligament is usually divided with ultrasonic shears. Next, the lesser sac is entered, and the short gastric vessels are divided.
  • If the surgeon prefers to "preligate," the splenic artery can be dissected along the superior border of the pancreas and can be divided with the vascular stapler. Otherwise, if feasible, the splenic vein and artery are exposed first and are dissected 1 cm proximal to the hilum, and they are usually divided with the vascular stapler. Then, the remainder of the spleen is released by dividing the peritoneal attachments with the ultrasonic scalpel. In other scenarios, the attachments are divided first and the spleen is rolled anteriorly to expose the tail of the pancreas and the hilar vessels posteriorly. These vessels are then transected with the laparoscopic vascular stapler. The spleen is placed into an EndoCatch bag and is morcellated and extracted through the largest trocar site.
  • Other laparoscopic approaches are the supine approach (with set-up similar to laparoscopic Nissen fundoplication) and the hand-assisted approach.
  • For the open approach, a standard midline incision or left subcostal incision (with possible Kehr extension up to the xiphocostal junction) may be used. Placing a large roll under the left flank often aids in exposure. Usually, the gastrocolic ligament is opened outside the gastroepiploic arcade and the splenic artery is identified along the superior border of the pancreas and then ligated. Next, the spleen is completely mobilized by dividing the avascular splenophrenic and splenorenal ligaments. The splenocolic ligament is divided, and the spleen is mobilized into the wound. The tail of the pancreas is separated from the splenic artery and vein, the splenic vessels are ligated, and the spleen is extracted.
  • Laparoscopic or open partial splenectomy should be attempted when feasible, due to the risk of lifelong susceptibility to infectious complications after splenectomy, particularly the rare, but highly fatal, overwhelming postsplenectomy sepsis. There are several techniques described for splenic repair.[19] The critical intraoperative maneuver regarding intraoperative splenic salvage entails fully mobilizing the spleen into the wound; this requires the division of 1 or 2 of the short gastric vessels combined with gentle dissection posteriorly, so that the capsule is not torn in the mobilization process.[6] Laparoscopic partial splenectomy also has been described, including for splenic abscess, using the ultrasonic scalpel or radiofrequency ablation for parenchymal division.[25, 26]
  • The use of postoperative drainage depends on the operative findings, including the presence of a frank abscess, and the proximity of the dissection to the pancreatic tail. The authors' preference is for closed suction drainage to be placed in the splenic bed, with early removal (ie, within 24 hours). There is some evidence that the routine use of drainage of the splenic bed in the absence of extrasplenic abscess or pancreatic injury is associated with an increased risk of local infection.
  • If concern exists regarding possible impingement upon the gastric wall during short gastric vessel division, a nasogastric tube may be left in place.
Previous
Next

Postoperative Details

  • Following splenectomy or global infarct, administer pneumococcal vaccine (Pneumovax) and vaccine against Haemophilus (if not given preoperatively).
  • Postoperative thrombocytosis occurs frequently. Antiplatelet therapy is initiated for platelet counts of greater than 1 million/mm3. However, antiplatelet therapy is controversial in this circumstance, and its benefit has not been demonstrated with a randomized, prospective, controlled trial.
  • The authors' current preferences for DVT prophylaxis are the use of sequential compression devices prior to incision and the postoperative employment of early ambulation and subcutaneous heparin.
  • Postoperative pain management may include intravenous PCA and possible epidural for cases requiring laparotomy.
Previous
Next

Follow-up

Follow-up is directed by the underlying cause of the infarction or abscess rather than by the absence of the spleen. Patients undergoing nonoperative management of splenic infarct, particularly a large infarct (when there is a concern that it will rupture), should be followed closely, with a low threshold for serial imaging.

Previous
Next

Complications

  • Pulmonary: pulmonary complications (e.g., pneumonia, atelectasis, etc.) were the most frequent complication (20%) in the UCLA series.[3] With the current trend of laparoscopic approach to splenectomy and partial splenectomy, this complication rate should be significantly reduced.
  • Infections - Postoperative abscess, fever, and wound infection are the second-most common complication (~10%). The first line of treatment is radiologically guided percutaneous drainage and antibiotics. A missed injury to a viscus (eg, stomach or colon) should be ruled out.
  • Hemorrhage - Hemorrhage, although relatively infrequent, can follow splenectomy due to the intense perisplenic inflammation.
  • Pancreatic fistula - Because of the intimate association of the pancreatic tail and the splenic hilum, pancreatic injury can occur, especially in the setting of intense inflammation and/or abscess. The majority of these injuries resolve with nonoperative management, which includes wide drainage, the use of a somatostatin analogue to decrease exocrine pancreatic function, and either total parenteral nutrition (TPN) or enteral alimentation distal to the ligament of Treitz.
  • Gastric fistula - Due to the intense inflammatory reaction that can accompany splenic abscess, the dissection of the spleen from the greater curve of the stomach can be difficult, and inadvertent, unrecognized injuries to the greater curve of the stomach do occur. With adequate external drainage and with no obstruction to normal gastric emptying, these can be treated expectantly with TPN or distal luminal alimentation and nasogastric tube decompression.
  • Overwhelming postsplenectomy sepsis - This is the most serious postsplenectomy complication; it occurs rarely (0.5%) in adult patients but carries a prohibitive mortality in unvaccinated patients. For this reason, a trend away from splenectomy and toward splenic conservation has emerged.
Previous
Next

Outcome and Prognosis

The prognosis varies with the underlying disease process responsible for splenic infarction. Splenectomies for infarction of massively enlarged spleens accompanying hematologic malignancies have reported mortality rates of as high as 35%. At the other end of the spectrum, many infarcts are clinically occult, with no significant long-term sequelae.

Asplenic individuals have an increased lifetime risk for developing overwhelming postsplenectomy sepsis, with the highest rate in the pediatric age group. Patients should be counseled to seek medical attention even for seemingly minor infections, because these can progress to fatal septicemia within hours.

These considerations have proven to be the impetus for splenic preservation.

Previous
Next

Future and Controversies

As laparoscopic techniques become more advanced, many of these surgical problems certainly will be amenable to laparoscopic splenectomy or partial splenectomy. There is great interest regarding the extension of the safe indications for splenic preservation. As technologies evolve, laparoscopic splenic preservation may become the future standard of care for segmental infarcts.

Previous
 
Contributor Information and Disclosures
Author

Manish Parikh, MD  Assistant Professor of Surgery, Department of Surgery, New York University School of Medicine; Attending Surgeon, Director Laparoscopic and Bariatric Surgery, Bellevue Hospital

Manish Parikh, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, and Society of American Gastrointestinal and Endoscopic Surgeons

Disclosure: Nothing to disclose.

Coauthor(s)

H Leon Pachter, MD, FACS  Chair, George David Stewart Professor, Department of Surgery, New York University Medical Center

H Leon Pachter, MD, FACS is a member of the following medical societies: American Association for the Surgery of Trauma, American College of Surgeons, American Surgical Association, American Trauma Society, New York Academy of Sciences, Society for Surgery of the Alimentary Tract, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Lewis J Kaplan, MD, FACS, FCCM, FCCP  Director, SICU and Surgical Critical Care Fellowship, Associate Professor, Department of Surgery, Section of Trauma, Surgical Critical Care, and Surgical Emergencies, Yale University School of Medicine

Lewis J Kaplan, MD, FACS, FCCM, FCCP is a member of the following medical societies: American Association for the Surgery of Trauma, American College of Surgeons, Association for Academic Surgery, Association for Surgical Education, Connecticut State Medical Society, Eastern Association for the Surgery of Trauma, International Trauma Anesthesia and Critical Care Society, Society for the Advancement of Blood Management, Society of Critical Care Medicine, and Surgical Infection Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Amy L Friedman, MD  Professor of Surgery, Director of Transplantation, State University of New York Upstate Medical University College of Medicine, Syracuse

Amy L Friedman, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Medical Women's Association, American Society for Artificial Internal Organs, American Society of Transplant Surgeons, American Society of Transplantation, Association for Academic Surgery, Association of Women Surgeons, International College of Surgeons, International Liver Transplantation Society, New York Academy of Sciences, Pennsylvania Medical Society, Philadelphia County Medical Society, Society of Critical Care Medicine, and Transplantation Society

Disclosure: Nothing to disclose.

Paolo Zamboni, MD  Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy

Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences

Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA  Vice Chair and Professor, Department of Surgery, Section of Gastrointestinal Medicine, and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director, Surgical Research, Department of Surgery, Yale-New Haven Hospital

John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract

Disclosure: AMGEN Royalty Consulting; ARdelyx Ownership interest Board membership

Additional Contributors

We wish to thank Amber A Guth, MD, FACS, Associate Professor, Department of Surgery, New York University Clinical Cancer Center, New York University School of Medicine, for her contribution to this article.

References
  1. Antopolsky M, Hiller N, Salameh S, et al. Splenic infarction: 10 years of experience. Am J Emerg Med. Mar 2009;27(3):262-5. [Medline].

  2. Edinburgh Med J. 1905;36.

  3. Nores M, Phillips EH, Morgenstern L. The clinical spectrum of splenic infarction. Am Surg. Feb 1998;64(2):182-8. [Medline].

  4. Jaroch MT, Broughan TA, Hermann RE. The natural history of splenic infarction. Surgery. Oct 1986;100(4):743-50. [Medline].

  5. Joshi SC, Pant I, Shukla AN, et al. Splenic infarct as a diagnostic pitfall in radiology. J Cancer Res Ther. Apr-Jun 2008;4(2):99-101. [Medline].

  6. Pachter HL, Guth AA, Hofstetter SR. Changing patterns in the management of splenic trauma: the impact of nonoperative management. Ann Surg. May 1998;227(5):708-17; discussion 717-9. [Medline]. [Full Text].

  7. Ebert EC, Nagar M, Hagspiel KD. Gastrointestinal and hepatic complications of sickle cell disease. Clin Gastroenterol Hepatol. Mar 4 2010;[Medline].

  8. Hayashi H, Beppu T, Okabe K, et al. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. Jun 2008;95(6):744-50. [Medline].

  9. Wu SC, Chen RJ, Yang AD, et al. Complications associated with embolization in the treatment of blunt splenic injury. World J Surg. Mar 2008;32(3):476-82. [Medline].

  10. Franklin QJ, Compeggie M. Splenic syndrome in sickle cell trait: four case presentations and a review of the literature. Mil Med. Mar 1999;164(3):230-3. [Medline].

  11. Sheikha A. Splenic syndrome in patients at high altitude with unrecognized sickle cell trait: splenectomy is often unnecessary. Can J Surg. Oct 2005;48(5):377-81. [Medline]. [Full Text].

  12. O'Keefe JH Jr, Holmes DR Jr, Schaff HV, et al. Thromboembolic splenic infarction. Mayo Clin Proc. Dec 1986;61(12):967-72. [Medline].

  13. Ting W, Silverman NA, Arzouman DA, et al. Splenic septic emboli in endocarditis. Circulation. Nov 1990;82(5 Suppl):IV105-9. [Medline].

  14. Yu LK, Hsu CW, Tseng JH, et al. Splenic infarction complicated by splenic artery occlusion after N-butyl-2-cyanoacrylate injection for gastric varices: case report. Gastrointest Endosc. Feb 2005;61(2):343-5. [Medline].

  15. Olson JF, Steuber CP, Hawkins E, et al. Functional deficiency of protein C associated with mesenteric venous thrombosis and splenic infarction. Am J Pediatr Hematol Oncol. Summer 1991;13(2):168-71. [Medline].

  16. Torda A. Postpartum toxic shock syndrome associated with multiple splenic infarcts. Med J Aust. 2005;182:93. [Medline]. [Full Text].

  17. Gupta BK, Sharma K, Nayak KC, et al. A case series of splenic infarction during acute malaria in northwest Rajasthan, India. Trans R Soc Trop Med Hyg. Jan 2010;104(1):81-3. [Medline].

  18. Desai DC, Hebra A, Davidoff AM. Wandering spleen: a challenging diagnosis. South Med J. Apr 1997;90(4):439-43. [Medline].

  19. Pachter HL, Hofstetter SR, Elkowitz A. Traumatic cysts of the spleen--the role of cystectomy and splenic preservation: experience with seven consecutive patients. J Trauma. Sep 1993;35(3):430-6. [Medline].

  20. Urban BA, Fishman EK. Helical CT of the spleen. AJR Am J Roentgenol. Apr 1998;170(4):997-1003. [Medline]. [Full Text].

  21. Balcar I, Seltzer SE, Davis S. CT patterns of splenic infarction: a clinical and experimental study. Radiology. Jun 1984;151(3):723-9. [Medline]. [Full Text].

  22. Kluger Y, Paul DB, Townsend RN. Enhanced rim around infarcted, traumatized spleen on computed tomographic scans: case report. J Trauma. Mar 1994;36(3):436-7. [Medline].

  23. Goerg C, Schwerk WB. Splenic infarction: sonographic patterns, diagnosis, follow-up, and complications. Radiology. Mar 1990;174(3 Pt 1):803-7. [Medline]. [Full Text].

  24. Cavazos S, Ratzer ER, Fenoglio ME. Laparoscopic management of the wandering spleen. J Laparoendosc Adv Surg Tech A. Aug 2004;14(4):227-9. [Medline].

  25. De Greef E, Hoffman I, Topal B, et al. Partial laparoscopic splenectomy for splenic abscess because of Salmonella infection: a case report. J Pediatr Surg. May 2008;43(5):E35-8. [Medline].

  26. Héry G, Becmeur F, Méfat L, et al. Laparoscopic partial splenectomy: indications and results of a multicenter retrospective study. Surg Endosc. Jan 2008;22(1):45-9. [Medline].

Previous
Next
 
Splenic infarct. Computed tomography scan of a 51-year-old man following a motor vehicle accident. American Association for the Surgery of Trauma (AAST) grade III splenic injury, with active extravasation of contrast from the splenic parenchyma (the white area along the medial aspect of the spleen).
Splenic infarct. Selective splenic arteriogram showing extravasation of contrast from the splenic artery at the splenic hilum prior to angioembolization (same patient as in the above image).
Computed tomography scan of the spleen 5 days after angioembolization of a bleeding splenic artery, showing partial splenic infarct (demonstrated by a lack of IV contrast enhancement of the lower pole of spleen). The patient experienced no adverse sequelae and fared well following his discharge to home 5 days after the embolization (same patient as in the above images).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.